openPR Logo
Press release

Gamma-Aminobutyric Acid (GABA) Receptor Market to Reckon increasing valuation by the end of year 2023

02-11-2019 02:21 PM CET | Health & Medicine

Press release from: Allied Market Research

Gamma-Aminobutyric Acid (GABA) Receptor Market

Gamma-Aminobutyric Acid (GABA) Receptor Market

Gamma-Aminobutyric acid (GABA) is an important inhibitory neurotransmitter found in the central nervous system of mammals. The neurotransmitter reduces the activity of neurons to which it binds, thus is used to control anxiety or fear when neurons are overexcited. GABA receptors are protein molecules that respond to neurotransmitter GABA.

Rise in incidences of neurological disorders and increase in aging population since the probability of developing Alzheimer's disease doubles every five years after the age of 65 drive the market. According to Alzheimers Association, the risk of developing Alzheimers is nearly 50% after the age 85. Moreover, increase in prevalence of risk factors (such as diabetes), and lifestyle changes (such as alcohol consumption) also increase the chances of developing a mental disorder.

Send Enquiry on this report @

This ultimately drive the market growth. However, low awareness, especially in developing nations; regarding treatment of mental disorders restrain the market growth. Increased funding by government and private organizations across emerging economies for treatment of neurological disorders is expected to provide growth opportunities for the market growth.

The global GABA market is segmented on the basis of type, application, and region. Based on type, the market is bifurcated into GABAA and GABAB. By application, it is classified into attention deficit hyperactivity disorder, psychiatric disorders, Alzheimers disease, chronic obstructive pulmonary disease, memory impairment, and other disorders. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players operating in the market include AgeneBio, Inc., F. Hoffmann-La Roche AG, Les Laboratoires Servier SAS, and Nutra Green Biotechnology Co.,Ltd.

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
• The report offers a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
• Exhaustive analysis by type helps to understand the types of GABA used and its application that are expected to gain prominence in the future.

Gamma-Aminobutyric Acid (GABA) Receptor Market Key Segments:

By Type


By Application

• Attention Deficit Hyperactivity Disorder
• Psychiatric Disorders
• Alzheimer's Disease
• Chronic Obstructive Pulmonary Disease
• Memory Impairment
• Other

For More Info Visit @

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.


David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gamma-Aminobutyric Acid (GABA) Receptor Market to Reckon increasing valuation by the end of year 2023 here

News-ID: 1577433 • Views: 202

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ Synthetic biology is at a nascent stage and has recently

All 5 Releases

More Releases for GABA

GABA Global Industry Report - History, Present and Future 2025
The global market size of GABA is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from
Gamma-Aminobutyric Acid (GABA) Receptor Market 2024 Industry Key Manufacturers, …
Gamma-Aminobutyric Acid (GABA) Receptor Market research report 2019-2024 presents a comprehensive study of the Gamma-Aminobutyric Acid (GABA) Receptor Market in Global Industry; the study scans the progression of the market trailed over the past few years and the forecasts of growth in the coming years, primarily in terms of sales. The research report highlights the reasons liable for the disparities in the market and investigates them methodically. The Gamma-Aminobutyric Acid
Herbal Toothpastes Market is Booming Worldwide | CCA, Church & Dwight, Colgate-P …
HTF MI recently Announced Global Chinese Herbal Toothpastes study with 100+ market data Tables and Figures spread through Pages and easy to understand detailed TOC on "Chinese Herbal Toothpastes. Global Chinese Herbal Toothpastes research allows you to get different methods for maximizing your profit. The research study provides estimates for Global Chinese Herbal Toothpastes Forecast till 2025*. Some of the Leading key Company’s Covered for this Research are CCA Industries,
GABA (CAS 56-12-2) Market will reach 46 million US$ in 2023
New report published by Global Info Research which offers insights on the global GABA (CAS 56-12-2) market. GABA (γ-aminobutyric acid) is a four carbon non-protein amino acid that is widely distributed in plants, animals and microorganisms. As a metabolic product of plants and microorganisms produced by the decarboxylation of glutamic acid, GABA functions as an inhibitory neurotransmitter in the brain that directly affects the personality and the stress management. A wide
Comprehensions on the GABA Market | Top Players - Pharma Foods International, Se …
HTF MI recently introduced Global GABA Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2025. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Pharma Foods International, Sekisui Chemical, Zhejiang YiWan Biolabs, Shanghai Richen, Guangdong Luckerkong
Global GABA Receptor Agonist Drug Market, Dosage, Price and Clinical Pipeline Ou …
Download Sample For Report Sample Contact: Report Weblink:,-dosage,-price-and-clinical-pipeline-outlook-2024.php Table of Contents 1. Prologue to (Gamma Amino Butyric Acid) GABA 1.1 Gamma - Amino Butyric Acid (GABA) andndash; Chief Inhibitory Neurotransmitter of the Central Nervous System 1.2 GABA Receptors and Their Importance 1.3 GABA Receptor - Role and it’s Working Mechanism 2. Major Classes of GABA Receptor Therapeutics 2.1 GABA Receptor Agonist (Activators) 2.2